CD44 and benign prostatic hyperplasia: In the TDLNs, all administrations of RZ activated DCs on D15, but on D20, the proportion of mDCs in the RZ (s.c.)and RZ (i.t.)groups decreased, while the RZ‐BPH group remained a high level of mDCs, increasing effector memory T cells (TEM, CD3+CD8+CD44+CD62L–) in the tumor (Figure 3j,k).